Implementation and Evaluation of Bump2Baby and Me+ Programme for Gestational Diabetes Mellitus in Routine Maternity Care Setting.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity College Dublin

About this trial

Gestational diabetes mellitus (GDM) affects approximately 1 in 7 pregnancies globally and is associated with significant short and long-term health consequences for both mothers and infants. While lifestyle interventions during pregnancy can effectively reduce GDM risk and its complications, there is limited guidance on how to translate this evidence into routine antenatal and postpartum care. This project looks to address this gap by exploring the effectiveness of the B2B\&Me+ programme within regular maternity services across four European countries and how best to implement it.

Women identified as being at higher risk of developing GDM using a GDM screening tool will receive access to the smartphone application that connects them with their health coach, who will provide personalised support about healthy eating, physical activity, mental wellbeing, and infant care from early pregnancy until 9 months after birth. The participants will be randomised initially to a specific referral pathway for the intervention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pregnant women attending their first/early antenatal appointments at participating sites

Gestation less than 24 weeks at enrolment

Age 18 years or older

Ability to provide informed consent

Disqualifiers

24 weeks gestation or higher

Multiple pregnancy (twins, triplets, etc.)

Participation in another health behaviour change intervention study during pregnancy

Inability to understand the language of the intervention (English in Ireland, Spanish in Spain, Norwegian in Norway, Polish in Poland)

Trial design

Design model

Sequential

Treatments tested in this trial

  • Life Style Intervention

    Behavioral

    The intervention consists of seven related components: I. A Bluetooth-enabled weighing scale that syncs with the app to facilitate self-monitoring of weight. II. Synchronous coaching sessions conducted on a 1:1 basis between the mHealth coach and participants. There will be 2 synchronous sessions, the first at enrolment and the second between 6-8 weeks postpartum. These sessions typically last 45-50 minutes in length with a follow-up summary video message of the goals discussed and, at the beginning of the mother's journey, the establishing of a change agreement. This is mediated through the live-video feature in the B2B\&Me+ mHealth coaching app, but the length and thus number of these sessions is determined by the woman. If the woman is diagnosed with GDM, there will be an opportunity for a third 15-minute synchronous coaching session to review and adjust any lifestyle goals to align with the individual's diabetes management plan. III. Asynchronous mHealth coaching that uses a combi

Treatment groups

3,600 Participants
are divided into 2 treatment groups
Group A: Block A (Usual care phases)No intervention 0 interventions
Group B: Block B (Intervention phase)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Penetration and participation rates in early pregnancy GDM screening and intervention

The primary analysis will compare penetration across the different blocks (A vs B), participation rates and different referral methods within Block B. This will be analysed using chi-square tests for categorical data and t-tests or ANOVA for continuous data.

Time frame
Immediately following intervention.

Secondary outcomes

1

Maternal Weight and BMI at baby's birth

Maternal weight (kg) and Body Mass Index (gestational weight gain)

Time frame
At birth of baby.
2

GDM incidence at baby's birth.

GDM incidence rate.

Time frame
At birth of baby
3

Adverse Birth Outcomes

Rates of adverse birth outcomes (pre-eclampsia, preterm birth, birth weight ≥4000g, birth trauma, neonatal respiratory distress, phototherapy, stillbirth/neonatal death, NICU admission or shoulder dystocia, caesarean section/interventions)

Time frame
Until birth of last baby included.
4

Breastfeeding Initiation.

Breastfeeding initiation rates and on discharge

Time frame
At discharge following birth of baby.

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University College Dublin

Lead sponsor

National Maternity Hospital, Ireland

Collaborator

Aarhus University Hospital

Collaborator

Liva Healthcare A/S

Collaborator

Western Norway University of Applied Sciences

Collaborator

University of Agder

Collaborator

Pomeranian Medical University Szczecin

Collaborator

Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental

Collaborator

Deakin University

Collaborator

This trial is not recruiting at the moment. You can still explore other options: